Opioid Risk Tool Guide

Key Takeaways

The opioid risk tool (ORT) is a validated, self-report screening instrument that estimates how likely a patient is to misuse opioids when prescribed them for chronic pain.

The original ORT scores risk as 0-3 (low), 4-7 (moderate), and 8 or higher (high); the revised ORT-OUD simplifies this to ≤2 (low) and ≥3 (high) for opioid use disorder specifically.

Administer the ORT at the initial visit before starting or continuing opioid therapy, and record the score in the patient’s chart for continuity and compliance.

Practice management software like Pabau lets clinicians capture, score, and track opioid risk tool results inside the patient record, so screening history stays with the rest of the chart over time.

Download your free opioid risk tool

The opioid risk tool (ORT) is a short, self-report questionnaire that scores a patient’s likelihood of misusing opioids before you start or continue opioid therapy for chronic pain. It takes about a minute to complete and sorts patients into low, moderate, or high opioid risk so you can match monitoring to the person in front of you.

This guide covers how to administer the opioid risk assessment tool, how to read each scoring band, when to reassess, and how the ORT compares with other opioid screening tools. Download the free PDF template above, then use the sections below to put it to work.

What is the opioid risk tool?

The opioid risk tool is a validated screening instrument that clinicians use to assess the likelihood a patient will develop opioid abuse or addiction when prescribed opioids for chronic pain, including conditions billed under M47.9 or M81.6.

Developed by Lynn R. Webster, MD, this ORT screening tool has become a standard in pain management, primary care, and mental health and addiction practices for risk stratification before opioid initiation or continuation.

The tool evaluates several risk factors at once: personal and family history of substance abuse, age, a history of preadolescent sexual abuse, psychological conditions (depression, anxiety, bipolar disorder, OCD, ADHD), and current alcohol or drug use. Scoring these domains sorts patients into low, moderate, or high-risk groups. That risk category then informs prescribing decisions and how closely you monitor.

The original opioid risk tool differs from the revised opioid risk tool (ORT-OUD), developed in 2019 to predict opioid use disorder specifically in patients with chronic non-malignant pain. Both versions remain in use, so knowing which one you are scoring matters, particularly as clinical guidelines increasingly recommend validated screening before opioid therapy.

How to administer the opioid risk tool

Administering the opioid risk tool through digital intake forms keeps assessment consistent and the results documented. The ORT is a self-report questionnaire, so patients can complete it on paper, a tablet, or an online form before the visit. The process breaks into five steps that fit clinical workflow:

1. Patient consent and introduction: Explain that the assessment helps identify risk factors so you can provide safer, more tailored pain management. Obtain consent and reassure the patient that responses are confidential and stored in their medical record.
2. Risk-factor assessment across five domains: The patient self-reports (or you assist) on family history of substance abuse (alcohol, illegal drugs, prescription drugs), personal history of substance abuse, age (higher risk if 16-45), preadolescent sexual abuse history, and current psychological conditions. Each domain carries a point value.
3. Scoring calculation: Sum the points from all domains. Item weights differ by sex in the original ORT, so use the values printed on the form. Then assign the total to a risk category: 0-3 = low risk, 4-7 = moderate risk, 8 or higher = high risk.
4. Result interpretation and documentation: Communicate the risk category to the patient in plain language. Record the total score, risk category, and your clinical reasoning in the patient’s clinical record right away. Note any protective factors, such as stable housing, employment, or a supportive family, that put the score in context.
5. Treatment planning and monitoring: Align the pain management plan with the risk category. Low-risk patients may proceed with standard opioid protocols. Moderate and high-risk patients benefit from closer monitoring, urine drug screening, or non-opioid alternatives. Use AI-powered clinical documentation to generate consistent, compliant progress notes after each visit.

Opioid risk tool scoring and interpretation

Correct opioid risk tool scoring is what makes the screen useful, because the same number drives different clinical responses. The original ORT (often shortened to ORT scoring) uses three risk bands, each calling for a different level of oversight:

The revised ORT-OUD simplifies the opioid risk tool score into two categories: 2 or lower is low risk for opioid use disorder, and 3 or higher is high risk. This version was designed specifically to predict OUD, which makes it useful in specialist settings focused on opioid use disorder prevention and treatment.

Both versions share a key limit: the ORT is a screening aid, not a diagnostic test. It cannot diagnose opioid use disorder. It flags patients who warrant closer monitoring or further evaluation, so read every result alongside patient history, behavioral observations, and other clinical markers.

A high opioid risk tool score is not a reason to withhold pain treatment. Patients who screen high still need effective analgesia. The score signals a need for closer monitoring, non-opioid or multimodal options where they fit, and, in some cases, referral to physical therapy or addiction specialists.

When to use the opioid risk tool: clinical scenarios

Initial opioid consultation: Administer the ORT before writing the first opioid prescription. This baseline assessment guides the whole treatment relationship and signals to the patient that risk screening is part of standard care.

Dose escalation: If a patient requests a higher dose or has been on stable therapy for months, re-administer the ORT to catch new risk factors, such as mood changes, increased alcohol use, or new psychiatric symptoms. Document the comparison between the baseline and current scores.

Annual comprehensive review: Even low-risk patients benefit from annual ORT readministration as part of routine pain management renewal, alongside a functional check such as a muscular strength test. Paperless documentation makes this longitudinal tracking straightforward, so you can see ORT trends across years and step in early if risk rises.

Telehealth and remote intake: The ORT suits automated intake workflows in telehealth settings. Patients complete the questionnaire digitally before the visit, and you review and discuss results during the consultation, saving time and keeping screening consistent across providers.

ORT vs. ORT-OUD vs. other opioid screening tools

Several validated opioid screening tools exist for misuse and opioid use disorder. Knowing the differences helps you pick the right instrument for your patient population and clinical setting:

• Original opioid risk tool (ORT): five-domain self-report, scoring 0-3 (low), 4-7 (moderate), or 8+ (high). Best for initial risk stratification in primary care and pain clinics, and validated across multiple specialties.
• Revised ORT-OUD: simplified two-category scoring (≤2 low, ≥3 high). Designed to predict opioid use disorder specifically. Preferred in addiction medicine and specialist pain settings, and published in The Journal of Pain (2019).
• SOAPP-R (Screener and Opioid Assessment for Patients with Pain – Revised): a 24-item self-report measuring aberrant drug-related behaviors. Longer than the ORT but captures psychosocial factors in more depth. Useful for moderate and high-risk patients who need detailed assessment.
• DIRE (Diagnosis, Intractability, Risk, Efficacy): a clinician-rated tool that scores diagnosis, intractability (how resistant the pain has been to conventional treatment), risk, and efficacy (the anticipated or observed benefit of opioids for pain and function), each element rated 1-3, for a total score of 7-21. Totals of 13 or lower suggest a less suitable candidate for long-term opioid therapy, and it’s often used alongside the ORT to build a fuller risk profile.
• COMM (Current Opioid Misuse Measure): a 17-item opioid misuse screening tool for patients already on opioids. Administered at follow-up visits rather than initial screening.
• RIOSORD (Risk Index for Overdose or Serious Opioid-Induced Respiratory Depression): predicts risk of overdose or serious respiratory depression rather than misuse. Useful when the concern is an overdose risk score rather than aberrant behavior.
• RODS (Rapid Opioid Dependence Screen): a brief OUD screening tool that checks for existing opioid dependence rather than future risk.

The ORT remains the most widely used initial opioid misuse screening tool thanks to its brevity, strong validation, and ease of use in busy settings. Many practices still pair it with SOAPP-R or DIRE for moderate and high-risk patients to build a more granular risk profile.

Streamline opioid risk screening in your practice

Pabau's digital forms and integrated clinical records make it easy to administer, score, and track opioid risk assessments. Capture ORT results at intake, generate compliant documentation, and follow each patient's risk over time, all in one platform.

Book a demo

Putting the opioid risk tool to work

The opioid risk tool is an evidence-based screen that helps you identify patients at elevated risk for opioid abuse or addiction before therapy starts. Administer it at the initial visit and track scores over time, and you can make safer prescribing decisions and set monitoring intensity to match each patient’s risk.

Consistent documentation and workflow are what turn a one-off screen into ongoing safety. Building opioid risk screening into your clinical record system keeps scores captured, retrievable, and useful for long-term care. Download the free opioid risk tool template above and start folding systematic risk screening into your pain management practice.

Continue your research

Want to automate clinical documentation after risk assessments? Pabau Scribe, our AI scribe, generates compliant notes from your clinical observations, saving time and cutting the documentation load.

Need to track patient compliance across visits? Patient compliance tools help monitor adherence to pain agreements and medication regimens.

Managing sensitive patient data? HIPAA compliance guidance keeps your ORT assessments and clinical records stored securely, protecting patient privacy and practice liability.

Frequently asked questions